​

NRx Pharmaceuticals (NRXP) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NRXP Stock Forecast

NRx Pharmaceuticals (NRXP) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $2.00, with a high of $2.00 and a low of $2.00. This represents a -36.31% decline from the last price of $3.14.

High: $2 Avg: $2 Low: $2 Last Closed Price: $3.14

NRXP Stock Rating

NRx Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

NRXP Price Target Upside V Benchmarks

TypeNameUpside
StockNRx Pharmaceuticals-36.31%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.14$3.14$3.14
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2513---4
Sep, 25-3---3
Aug, 25-3---3
Jul, 25-3---3
Jun, 25-3---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 30, 2022Vernon BernardinoH.C. Wainwright$2.00$0.57250.88%-36.31%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 08, 2025H.C. WainwrightBuyBuyinitialise
Aug 25, 2025BTIGBuyBuyhold
Apr 02, 2025BTIGBuyinitialise
Oct 21, 2024EF HuttonBuyinitialise
Aug 02, 2024H.C. WainwrightBuyBuyhold
Jun 30, 2022H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

$-5 $0 $5 $10 $15 $20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.98$-2.39----
Avg Forecast$-2.92$-1.86$0.32$1.12$4.06$8.71
High Forecast$-1.77$-0.79$0.56$1.94$7.05$15.12
Low Forecast$-4.07$-3.22$0.14$0.48$1.73$3.70
Surprise %36.30%28.49%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$6.70M$68.47M$180.28M$518.62M$1.05B
High Forecast-$10.49M$107.21M$282.30M$812.11M$1.65B
Low Forecast-$3.74M$38.20M$100.57M$289.32M$588.07M
Surprise %------

Net Income Forecast

$-50M $-10M $30M $70M $110M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-30.15M$-25.13M----
Avg Forecast$-30.16M$-20.39M$2.62M$9.17M$33.23M$65.99M
High Forecast$-13.42M$-5.98M$4.21M$14.73M$53.39M$114.53M
Low Forecast$-30.82M$-24.41M$1.03M$3.61M$13.08M$28.06M
Surprise %-0.03%23.23%----

NRXP Forecast FAQ

Is NRx Pharmaceuticals stock a buy?

NRx Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that NRx Pharmaceuticals is a favorable investment for most analysts.

What is NRx Pharmaceuticals's price target?

NRx Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $2 over the next 12 months. The price target range spans from $2 at the low end to $2 at the high end, suggesting a potential -36.31% change from the previous closing price of $3.14.

How does NRx Pharmaceuticals stock forecast compare to its benchmarks?

NRx Pharmaceuticals's stock forecast shows a -36.31% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for NRx Pharmaceuticals over the past three months?

  • October 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is NRx Pharmaceuticals’s EPS forecast?

NRx Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $0.32, marking a -113.39% decrease from the reported $-2.39 in 2024. Estimates for the following years are $1.12 in 2026, $4.06 in 2027, and $8.71 in 2028.

What is NRx Pharmaceuticals’s revenue forecast?

NRx Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $68.47M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $180.28M, followed by $518.62M for 2027, and $1.05B for 2028.

What is NRx Pharmaceuticals’s net income forecast?

NRx Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $2.62M, representing a -110.43% decrease from the reported $-25.126M in 2024. Projections indicate $9.17M in 2026, $33.23M in 2027, and $65.99M in 2028.